Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 23
Meet the EuroMinnies 2023 semifinal candidates
The list of candidates for the fifth edition of the EuroMinnies awards scheme is now available, following the large number of nominations submitted by the members of
AuntMinnieEurope.com
. Find out who's made the shortlist in the nine categories.
December 13, 2022
Ultrasound sheds light on axillary staging in breast cancer
By
Frances Rylands-Monk
Researchers from Turkey have found that asymmetrical cortical enlargement on the side closer to the breast, abnormal microvascular pattern, and high cortex-hilum ratio are independent predictors of axillary nodal involvement.
December 13, 2022
Novartis receives approval for Pluvicto
By
AuntMinnieEurope.com staff writers
Novartis has secured approval from the European Commission for its Pluvicto lutetium-177 prostate-specific membrane antigen radioligand therapy.
December 12, 2022
EANM seeks committee members
By
AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) is seeking a new member for its Physics Committee and two new members for its Translational Molecular Imaging and Therapy Committee.
December 6, 2022
ESR, EIBIR highlight 2020 Seed Grant research
By
AuntMinnieEurope.com staff writers
The European Society of Radiology (ESR) and the European Institute for Biomedical Imaging Research (EIBIR) are highlighting research that has emerged from eight 2020's Seed Grant medical imaging projects and is now coming to a close.
December 5, 2022
Blue Earth promotes PSMA radiotracer study
By
AuntMinnieEurope.com staff writers
Blue Earth Diagnostics has released top-line results from its phase III trial evaluating the performance of its prostate-specific membrane antigen (PSMA) radiotracer for imaging in newly diagnosed prostate cancer.
December 4, 2022
Kuhl provides research update on gadolinium-based contrast agent
CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about the product's potential, we spoke with Prof. Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022.
December 4, 2022
French group flies the flag for Europe in RSNA poster hall
By
Philip Ward
Members of a research group in Nantes -- known as the jewel of the Loire Valley in northwest France -- received Europe's only magna cum laude award when the prestigious prizes were handed out on day 4 of the RSNA meeting.
November 30, 2022
What's the most cost-effective way to diagnose liver metastases?
By
Kate Madden Yee
CHICAGO - MRI appears to be the most cost-effective modality for diagnosing colorectal cancer liver metastases, according to a German study presented in a 27 November session at RSNA 2022.
November 27, 2022
Krakow welcomes ISHRAD to celebrate Poland's rich history
By
Dr. Arpan K. Banerjee
The early days of PET scanning, along with the role of Nordic pioneers, were popular topics at the annual congress of the International Society for the History of Radiology (ISHRAD) in Krakow, Poland.
November 24, 2022
Hybrid imaging meeting attracts more than 2K attendees
By
Kate Madden Yee
The Conference on Hybrid Imaging Live (CHILI 5.0) held virtually on 11 November attracted more than 2,000 attendees from 133 countries, according to its sponsor, the European Society for Hybrid, Molecular, and Translational Imaging (ESHIMT).
November 20, 2022
Dutch team evaluates bone formation in psoriatic arthritis patients
By
Will Morton
Researchers from Amsterdam UMC have reported that F-18 sodium fluoride PET/CT may be a valuable tool for imaging patients with psoriatic arthritis because it reveals new bone formation missed on clinical evaluation of peripheral joints.
November 20, 2022
Previous Page
Page 23 of 124
Next Page